About Biomedical Warming and Thawing Devices
Warming and thawing processes have been widely used in the biopharmaceutical industry to revive cryopreserved cells and then use them to manufacture various biopharmaceutical drugs. Human cells, DNA, and proteins that have been frozen and held at low temperatures must be thawed in order to make biopharmaceutical compounds. Several constraints, such as strict regulations for thawed biomedical products and samples, as well as issues with large batch sizes, could slow market growth in the long run. The demand for warming and thawing devices is being boosted by the presence of a large number of blood banks and transfusion centres in some of the regions where frozen samples are processed and thawed properly for further transfusion in patients.
Attributes | Details |
---|
Study Period | 2017-2027 |
Base Year | 2021 |
Unit | Value (USD Million) |
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Biomedical Warming and Thawing Devices market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.
GE Healthcare (United States), Thermo Fisher Scientific (United States), Helmer Scientific (United States), Sarstedt AG & Co. KG (Germany), Sartorius AG (Germany), CytoTherm (United States), Barkey Medical Technology (Germany), Boekel Scientific (United States) and Cardinal Health (United States) are some of the key players that are part of study coverage.
Segmentation Overview
AMA Research has segmented the market of Global Biomedical Warming and Thawing Devices market by Type (Automatic and Manual), Application (Hospital, Laboratory, Research Institutions and Others) and Region.
On the basis of geography, the market of Biomedical Warming and Thawing Devices has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Sample, the sub-segment i.e. Blood Products will boost the Biomedical Warming and Thawing Devices market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
Influencing Trend:
Increased development of sample analysis and studies in the biotechnology sector
Market Growth Drivers:
Growing number of blood banks and blood infusion centers worldwide and Increasing number of road accidents and trauma cases leading to blood transfusions
Challenges:
Issues related to large batch size
Restraints:
Strict regulations related to thawed biomedical products and samples
Opportunities:
Growing government initiatives around the globe have helped the healthcare sector by providing superior quality medical devices
Key Target Audience
Venture Capitalists and Private Equity Firms, New Entrants/Investors, Analysts and Strategic Business Planners, Biomedical Warming and Thawing Devices Suppliers, Raw Material Suppliers, Government Regulatory and Research Organizations and End-Use Industries
About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.
Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.
The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.